Enorden en es it fr

Enorden Brand names, Enorden Analogs

Enorden Brand Names Mixture

  • No information avaliable

Enorden Chemical_Formula


Enorden RX_link

No information avaliable

Enorden fda sheet

Enorden msds (material safety sheet)

Enorden Synthesis Reference

No information avaliable

Enorden Molecular Weight

309.469 g/mol

Enorden Melting Point

< 25 oC

Enorden H2O Solubility

Soluble as HCl salt

Enorden State


Enorden LogP


Enorden Dosage Forms

Tablets (oral, 1 mg)

Enorden Indication

Used for the symptomatic treatment of parkinsonism.

Enorden Pharmacology

Metixene is a tertiary antimuscarinic with actions similar to those of atropine; it also has antihistaminic and direct antispasmodic properties. It is used for the symptomatic treatment of parkinsonism, including the alleviation of the extrapyramidal syndrome induced by other drugs such as phenothiazines, but, like other antimuscarinics, it is of no value against tardive dyskinesias. Metixene has been discontinued.

Enorden Absorption

Absorbed in the gastrointestinal tract following oral administration, however the extent of absorption is not known.

Enorden side effects and Toxicity

Signs of overdose include dilated and sluggish pupils, warm, dry skin, facial flushing, decreased secretions of the mouth, pharynx, nose, and bronchi, foul-smelling breath, elevated temperature, tachycardia, cardiac arrhythmias, decreased bowel sounds, urinary retention, delirium, disorientation, anxiety, hallucinations, illusions, confusion, incoherence, agitation, hyperactivity, ataxia, loss of memory, paranoia, combativeness, and seizures.

Enorden Patient Information

Enorden Organisms Affected

Humans and other mammals